These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 211593)
1. [The interaction between drugs and oral anticoagulants of the coumarin group]. Verstraete M Sem Hop; 1978 May; 54(13-16):505-8. PubMed ID: 211593 [TBL] [Abstract][Full Text] [Related]
2. [Oral anticoagulation with vitamin K antagonists]. Alberio L Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470 [TBL] [Abstract][Full Text] [Related]
3. [Drug interactions in coumarin anticoagulation]. Kessler P Vnitr Lek; 1999 Aug; 45(8):490-5. PubMed ID: 11045152 [TBL] [Abstract][Full Text] [Related]
4. Dietary vitamin K1 and stability of oral anticoagulation: proposal of a diet with constant vitamin K1 content. Booth SL; Charnley JM; Sadowski JA; Saltzman E; Bovill EG; Cushman M Thromb Haemost; 1997 Mar; 77(3):504-9. PubMed ID: 9066002 [TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic and pharmacokinetic drug interactions with coumarin anticoagulants. MacLeod SM; Sellers EM Drugs; 1976; 11(6):461-70. PubMed ID: 782840 [TBL] [Abstract][Full Text] [Related]
9. [Adverse reactions of coumarin derivative interactions]. Wiela-Hojeńska A; Orzechowska-Juzwenko K Pol Merkur Lekarski; 2000 Sep; 9(51):600-1. PubMed ID: 11126983 [TBL] [Abstract][Full Text] [Related]
10. New anticoagulants for atrial fibrillation. De Caterina R; Kristensen SD; Renda G J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276 [TBL] [Abstract][Full Text] [Related]
11. Inhibition rather than enhancement of hemostatic system activation during initiation of oral anticoagulant treatment. Kyrle PA; Brockmeier J; Weltermann A; Eichinger S; Speiser W; Lechner K; Eichler HG Thromb Haemost; 1997 Apr; 77(4):685-9. PubMed ID: 9134643 [TBL] [Abstract][Full Text] [Related]
12. The pharmacodynamics of the oral anticoagulant drugs. O'Reilly RA Prog Hemost Thromb; 1974; 2(0):175-213. PubMed ID: 4137288 [No Abstract] [Full Text] [Related]
13. Drug therapy review--coumarin and indandione derivatives. Am J Hosp Pharm; 1973 Aug; 30(8):705-13. PubMed ID: 4579074 [No Abstract] [Full Text] [Related]
14. Vitamin K and the oral anticoagulant drugs. O'Reilly RA Annu Rev Med; 1976; 27():245-61. PubMed ID: 779597 [TBL] [Abstract][Full Text] [Related]
15. [Anticoagulation by oral treatment with vitamin K antagonists]. Kemkes-Matthes B Hamostaseologie; 2008 Dec; 28(5):421-7. PubMed ID: 19132171 [TBL] [Abstract][Full Text] [Related]
16. The pharmacology of oral anticoagulants: implications for therapy. Shetty HG; Woods F; Routledge PA J Heart Valve Dis; 1993 Jan; 2(1):53-62. PubMed ID: 8269110 [TBL] [Abstract][Full Text] [Related]
17. Antagonists of Vitamin K-Popular Coumarin Drugs and New Synthetic and Natural Coumarin Derivatives. Kasperkiewicz K; Ponczek MB; Owczarek J; Guga P; Budzisz E Molecules; 2020 Mar; 25(6):. PubMed ID: 32213944 [TBL] [Abstract][Full Text] [Related]
18. Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants. Visser LE; van Schaik RH; van Vliet M; Trienekens PH; De Smet PA; Vulto AG; Hofman A; van Duijn CM; Stricker BH Clin Pharmacol Ther; 2005 Jun; 77(6):479-85. PubMed ID: 15961979 [TBL] [Abstract][Full Text] [Related]